# FDA Inspection 1022901 - Steven L. Duckor, M.D. - July 28, 2017

Source: https://www.keypedia.com/records/fda_inspections/steven-l-duckor-md/3da20c4b-0726-4db4-811c-66c30657ae7e
Source feed: FDA_Inspections

> FDA Inspection 1022901 for Steven L. Duckor, M.D. on July 28, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1022901
- Company Name: Steven L. Duckor, M.D.
- Inspection Date: 2017-07-28
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 790980 - 2012-07-10](https://www.keypedia.com/records/fda_inspections/steven-l-duckor-md/18241dd6-86c1-407e-acc7-fa526b0aa4ea)
- [FDA Inspection 645154 - 2010-02-08](https://www.keypedia.com/records/fda_inspections/steven-l-duckor-md/fc1882ae-a6ff-426f-9a64-94138164bafc)
- [FDA Inspection 562001 - 2009-01-12](https://www.keypedia.com/records/fda_inspections/steven-l-duckor-md/d5915f91-c822-4dfa-91a8-b848356c8657)

Company: https://www.keypedia.com/companies/steven-l-duckor-md/cd9095a7-9659-4605-a819-b86cda7821f3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c